Abstract:Protein homeostasis (proteostasis) requires the timely degradation of misfolded proteins and their aggregates by protein quality control (PQC), of which molecular chaperones are an essential component. Compared with other cell types, PQC in neurons is particularly challenging because they have a unique cellular structure with long extensions. Making it worse, neurons are postmitotic, i.e., cannot dilute toxic substances by division, and, thus, are highly sensitive to misfolded proteins, especially as they age. Failure in PQC is often associated with neurodegenerative diseases, such as Huntington's disease (HD), Alzheimer's disease (AD), Parkinson's disease (PD), and prion disease. In fact, many neurodegenerative diseases are considered to be protein misfolding disorders. To prevent the accumulation of disease-causing aggregates, neurons utilize a repertoire of chaperones that recognize misfolded proteins through exposed hydrophobic surfaces and assist their refolding. If such an effort fails, chaperones can facilitate the degradation of terminally misfolded proteins through either the ubiquitin (Ub)-proteasome system (UPS) or the autophagy-lysosome system (hereafter autophagy). If soluble, the substrates associated with chaperones, such as Hsp70, are ubiquitinated by Ub ligases and degraded through the proteasome complex. Some misfolded proteins carrying the KFERQ motif are recognized by the chaperone Hsc70 and delivered to the lysosomal lumen through a process called, chaperone-mediated autophagy (CMA). Aggregation-prone misfolded proteins that remain unprocessed are directed to macroautophagy in which cargoes are collected by adaptors, such as p62/SQSTM-1/Sequestosome-1, and delivered to the autophagosome for lysosomal degradation. The aggregates that have survived all these refolding/degradative processes can still be directly dissolved, i.e., disaggregated by chaperones. Studies have shown that molecular chaperones alleviate the pathogenic symptoms by neurodegeneration-causing protein aggregates. Chaperone-inducing drugs and anti-aggregation drugs are actively exploited for beneficial effects on symptoms of disease. Here, we discuss how chaperones protect misfolded proteins from aggregation and mediate the degradation of terminally misfolded proteins in collaboration with cellular degradative machinery. The topics also include therapeutic approaches to improve the expression and turnover of molecular chaperones and to develop anti-aggregation drugs.

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity

Protein Aggregation: Opposing Effects of Chaperones and Crowding

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

Protein Quality Control by Molecular Chaperones in Neurodegeneration

Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens

Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network

Modulation of Amyloid States by Molecular Chaperones

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases

Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes

TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport

Chaperone Suppression of Cellular Toxicity of Huntingtin Is Independent of Polyglutamine Aggregation

Co-aggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

CCDC50 mediates the clearance of protein aggregates to prevent cellular proteotoxicity

TDP43 and Huntingtin Exon-1 Undergo A Conformationally Specific Interaction That Strongly Alters the Fibril Formation of Both Proteins

Heat Shock Proteins Reduce Aggregation and Facilitate Degradation of Tau Protein

Protein rescue from aggregates by powerful molecular chaperone machines